Since OA treatment attenuates the glucose intolerance with similar blood insulin levels as T2D-Veh mice, the improved glucose tolerance and glycemia in T2D-OA mice is probably due to improved insulin sensitivity of the peripheral tissues. This evidence concerns the gene INS and type 2 diabetes mellitus.